Industrial Distribution

Shenzhen·Chengdu·Beijing·Shanghai four-in-one modern biomedicine group company





Beijing Clinical Research Department, responsible for the formulation and implementation of clinical study protocols for new drugs, is an important technical center that contributes to the approval of new drug registration.

Chengdu Chipscreen Pharmaceutical Co., Ltd., located in Chengdu High-tech Zone, is the production base of Chiglitazar Sodium and Chiauranib, and the regional R&D center and regional headquarters of innovative drugs.

Shanghai Business Center, the marketing center of tumor products, the marketing center of metabolic disease products, and the product strategy and business development center.

Shenzhen Chipscreen Biosciences, Ltd. (Group Headquarters), located in Nanshan High-tech Zone, Shenzhen, is the innovative drug development and management center of the Company. Shenzhen Chipscreen Pharmaceutical Co., Ltd., located in Pingshan District, Shenzhen, is the production base of Chidamide.

Shenzhen Chipscreen Pharmaceutical Co., Ltd

Shenzhen Chipscreen Pharmaceutical Co., Ltd

Shenzhen Chipscreen Pharmaceutical Co., Ltd. (hereinafter referred to as "Shenzhen Chipscreen Pharmaceutical"), established on March 16, 2017, is a wholly-owned subsidiary of Shenzhen Chipscreen Biosciences, Co., Ltd. Formerly known as the Chipscreen Pingshan Production Base covering an area of 13,000 square meters, its major facilities include Antineoplastic API Workshop and Preparation Workshop, Quality Management Center, and Dangerous Goods Warehouse.

As the innovative medicine CMC technology transfer center of the Group and the industrialization base of the company's first novel antitumor drug - Chidamide, and adhering to the concept of "Quality by Design", Shenzhen Chipscreen Pharmaceutical has been incorporated into the whole life cycle and the whole chain risk management system of the group company. Through establishing and improving the qualified person system, quality assurance system, and EHS management system, it has enabled whole-process quality monitoring of pharmaceutical production.